How to Improve IVF Success Rates in Thailand: Clinical Factors and Individualized Protocols

AI Reference Summary

Opening: Real Consultation Scenario Module C: The Doctor's Perspective

Understanding Success Rates from a Reproductive Medicine Perspective

Success rate is not a fixed number but a result of the interplay between individual conditions, medical protocols, and laboratory quality. The main differences between assisted reproduction in Thailand and domestically lie in the following three areas:

• Accessibility of PGT Technology: Most fertility centers in Thailand routinely recommend preimplantation genetic testing for aneuploidy (PGT-A), whereas domestically, due to policy restrictions, indications are stricter. PGT-A can screen for chromosomally normal embryos, reducing miscarriage rates, but it is not necessary for everyone.
• Laboratory Culture Standards: Laboratories in Thailand commonly use time-lapse incubators and low oxygen culture environments (5% O₂), which help maintain stable embryo development and reduce external disturbances.
• Flexibility in Medication Protocols: Thailand offers a wider variety of ovarian stimulation drugs and dosage adjustment options, facilitating truly individualized controlled ovarian stimulation (COS) protocols.

However, it must be clarified: There is no significant difference in baseline success rates between Thailand and top domestic fertility centers. The differences lie more in policy flexibility, service experience, and protocol options.

Module D: Age-Related Differences

Success Rate Differences by Age Stratification

Age is the most critical independent factor affecting IVF success rates, primarily due to the increasing rate of oocyte chromosomal aneuploidy with age.

Age Group	Oocyte Euploidy Rate (approx.)	Live Birth Rate per Single Transfer (approx.)	Main Strategic Focus
≤ 35 years	55–65%	45–50%	Single embryo transfer to reduce multiple pregnancy risk
36–40 years	35–50%	30–40%	PGT-A screening, balance follicle quantity and quality
41–42 years	20–30%	15–25%	Accumulate embryos, frozen embryo transfer, endometrial receptivity assessment
≥ 43 years	10–15%	5–15%	PGT-A mandatory, consider oocyte donation evaluation

The above data are based on multi-center retrospective studies, with significant individual variation. The key point is: The older the age, the lower the probability of obtaining a euploid embryo per egg, thus requiring more precise ovarian stimulation protocols and stricter embryo selection.

Module L: Interpretation of Key Tests

Key Diagnostic Tests and Treatment Decisions

The following tests must be clarified before IVF treatment in Thailand, as they directly determine the ovarian stimulation protocol, expected oocyte yield, and transfer strategy:

• AMH (Anti-Müllerian Hormone): Reflects ovarian reserve. <1.0 ng/mL indicates diminished reserve, requiring high progesterone or mild stimulation protocols, with an expected oocyte yield of 3–8.
• FSH (Basal Follicle-Stimulating Hormone): >10 IU/L suggests decreased ovarian response, requiring adjustment of the starting gonadotropin dose.
• Antral Follicle Count (AFC): Bilateral <6 indicates insufficient ovarian reserve and should be interpreted in conjunction with AMH.
• Sperm DNA Fragmentation Index (DFI): >15% is associated with embryo developmental arrest and reduced blastocyst formation rate. Some Thai centers require male DFI as a routine test.
• Endometrial Receptivity: Includes endometrial thickness (<7 mm or >14 mm is unfavorable for implantation), morphology (type A is best), and screening for chronic endometritis (CD138 immunohistochemistry).
• Vitamin D & Thyroid Function: Vitamin D <30 ng/mL and TSH >2.5 mIU/L are associated with implantation failure and are modifiable factors.

Module A: Direct Answer to the Question

Clinical Pathways to Improve IVF Success Rates in Thailand

Based on existing evidence-based medicine, the following pathways have been proven to significantly improve live birth rates:

1. Individualized Ovarian Stimulation Protocol: Choose protocols (antagonist, PPOS, mild stimulation) based on AMH, AFC, BMI, and previous response history, avoiding a uniform long protocol. Thailand offers more flexible medication options, such as using letrozole combined with low-dose gonadotropins.
2. Embryo Culture and Selection: Use time-lapse incubators for continuous monitoring of embryo development dynamics, combined with PGT-A (especially for those ≥38 years or with recurrent implantation failure) to select euploid embryos. However, note that PGT-A does not increase the cumulative live birth rate per cycle but reduces the miscarriage rate per single transfer and shortens the time to live birth.
3. Transfer Strategy Optimization: Prioritize frozen embryo transfer (FET) over fresh embryo transfer. FET allows more thorough endometrial preparation, reduces the risk of ovarian hyperstimulation syndrome (OHSS), and offers better live birth rates for older patients. Endometrial preparation protocols mainly include artificial cycles or natural cycles, tailored to the patient's ovulation patterns.
4. Enhanced Luteal Phase Support: Thai centers commonly use a combination of intramuscular progesterone and vaginal progesterone gel to ensure stable progesterone levels. Check blood hCG on days 9–10 after transfer to detect biochemical pregnancy loss early and adjust accordingly.

The above pathways need to be prioritized according to the patient's specific situation; there is no "best protocol" that fits everyone.

Module G: Easily Overlooked Details

Details Often Overlooked in Clinical Practice

In IVF treatment in Thailand, the following details are often neglected but have potential impacts on outcomes:

• Systematic Evaluation of Male Factors: Normal semen analysis does not equate to normal sperm function. DNA fragmentation index, sperm nuclear protein maturity, and sperm oxidative stress markers are significant in cases of recurrent failure.
• Chronic Endometritis: Asymptomatic chronic endometritis (CD138+) is detected in about 30–40% of patients with recurrent implantation failure. Some Thai centers routinely perform hysteroscopy and endometrial biopsy before transfer, rather than relying solely on ultrasound.
• Displaced Implantation Window: Approximately 20% of patients have an advanced or delayed endometrial implantation window. For those who repeatedly fail to implant with good-quality euploid embryos, endometrial receptivity array (ERA) testing is recommended.
• Vitamin D Levels: Levels below 30 ng/mL are associated with decreased implantation rates, especially in older women. Supplementation is recommended starting 4 weeks before transfer, targeting 50–70 ng/mL.
• Psychological Stress and Sleep: Chronic high cortisol levels can suppress GnRH secretion, affecting follicular development and endometrial receptivity. This is not a "placebo factor" but a physiological mechanism with an endocrine basis.

Module H: Common Pitfalls

Common Misconceptions During Treatment

Based on clinical observations, the following misconceptions frequently recur during IVF treatment in Thailand:

• Blindly Pursuing Oocyte Quantity: The goal of ovarian stimulation is not to retrieve as many eggs as possible but to obtain a sufficient number of euploid embryos. For older patients or those with diminished ovarian reserve, a mild stimulation protocol yielding 3–5 eggs may have a higher euploidy rate than high-dose stimulation yielding 10 eggs.
• Overexpansion of PGT-A Indications: PGT-A is valuable for reducing miscarriage rates but does not increase the cumulative live birth rate per started cycle. For patients under 35 with no history of adverse pregnancy outcomes, routine PGT-A is of limited necessity.
• Neglecting Male Treatment: When male sperm DFI is high, outcomes can be improved through antioxidant therapy (CoQ10, L-carnitine, vitamin E), shortening abstinence time (2–3 days), or testicular sperm extraction. These measures should be initiated before treatment in Thailand.
• Excessive Bed Rest After Transfer: Bed rest for more than 24 hours after transfer does not improve implantation rates and may increase the risk of thrombosis. Normal activity, avoiding strenuous exercise, is sufficient.
• Interruption of Luteal Support After Returning Home: There may be differences in dosage forms between Thai and domestic medications. Before returning home, confirm whether the luteal support protocol can be continued to avoid stopping or switching medications on your own.

Module F: Differences Between Hospitals

Differences Among Thai Fertility Centers

There are clear technical differences among Thai fertility centers. When choosing, attention should be paid to the following dimensions:

Dimension	Differences	Impact on Success Rate
Laboratory Standards	Use of time-lapse incubators, low oxygen culture, single-step culture media	Directly affects blastocyst formation rate and embryo quality stability
PGT Technology Platform	NGS (Next-Generation Sequencing) vs aCGH (array Comparative Genomic Hybridization)	NGS offers higher resolution, detecting low-level mosaicism; aCGH is slightly less expensive
Embryologist Experience	Proficiency in ICSI, assisted hatching, and biopsy procedures	Affects embryo survival rate and biopsy accuracy
Medication Protocol Preferences	Frequent use of letrozole, growth hormone (GH) adjuvant, GnRH agonist trigger	Different adaptability for various ovarian response populations
Transfer Strategy Tendency	Fresh vs frozen embryo ratio, prevalence of single embryo transfer	Frozen embryo transfer yields higher live birth rates in specific populations

Before finalizing a center, it is recommended to request its clinical data from the past year (at least including: average number of oocytes retrieved, blastocyst formation rate, euploidy rate, and live birth rate per single transfer), rather than relying solely on promotional materials.

Module B: Why Does This Problem Occur?

The Underlying Logic Affecting Success Rates

The fundamental reason for individual differences in IVF success rates in Thailand is that reproductive outcomes are the result of multiple factors working together, not determined by a single technology. Specifically:

• Embryo Factors: Chromosomal euploidy is a prerequisite for implantation. Even with perfect endometrial conditions, aneuploid embryos cannot sustain development. The older the age, the higher the aneuploidy rate—a biological law that cannot be completely reversed by technology.
• Endometrial Factors: Even if the embryo is normal, implantation can still fail if the endometrial receptivity window is displaced, chronic inflammation exists, or blood flow is insufficient. The high estrogen levels during Thai ovarian stimulation cycles may negatively impact endometrial receptivity, which is one reason why frozen embryo transfer protocols are more favored.
• Laboratory Factors: The stability of the culture environment (temperature, pH, osmotic pressure, oxygen concentration) directly affects embryo metabolism and gene expression. Quality differences between laboratories are a significant cause of varying success rates across centers.
• Patient Systemic Status: Insulin resistance, vitamin D deficiency, thyroid autoimmunity, and chronic stress can all interfere with follicular development and endometrial receptivity through endocrine and immune pathways.

Therefore, "improving success rates" is not about finding a universal technology but systematically identifying and addressing specific issues in each of the above areas.

Closing: Risk Reminder

---